Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

NCT03534323

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • University of Miami- Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Northern Light Eastern Maine Medical Center Brewer, Maine, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

NCT02773030

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 102 Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Local Institution - 107 Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 162 locations
View Trial Details
Active, Not Recruiting

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

NCT02503423

Conditions
Carcinoma, Carcinoma, Squamous Cell, Female Urogenital Diseases, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

FT819 in Subjects With B-cell Malignancies

NCT04629729

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Arizona Phoenix, Arizona, United States
  • UC Davis Davis, California, United States
  • Scripps Green Hospital La Jolla, California, United States
View all 18 locations
View Trial Details

Related conditions